Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Low level of exosomal long non-coding RNA HOTTIP is a prognostic biomarker in colorectal cancer.

Oehme F, Krahl S, Gyorffy B, Muessle B, Rao V, Greif H, Ziegler N, Lin K, Thepkaysone ML, Polster H, Tonn T, Schneider M, Weitz J, Baenke F, Kahlert C.

RNA Biol. 2019 Oct;16(10):1339-1345. doi: 10.1080/15476286.2019.1637697. Epub 2019 Jul 7. Erratum in: RNA Biol. 2019 Oct 3;:1.

PMID:
31251124
2.

Expression of Glypican 3 is an Independent Prognostic Biomarker in Primary Gastro-Esophageal Adenocarcinoma and Corresponding Serum Exosomes.

Rahbari M, Pecqueux M, Aust D, Stephan H, Tiebel O, Chatzigeorgiou A, Tonn T, Baenke F, Rao V, Ziegler N, Greif H, Lin K, Weitz J, Rahbari NN, Kahlert C.

J Clin Med. 2019 May 16;8(5). pii: E696. doi: 10.3390/jcm8050696.

3.

Publisher Correction: Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma.

Trucco LD, Mundra PA, Hogan K, Garcia-Martinez P, Viros A, Mandal AK, Macagno N, Gaudy-Marqueste C, Allan D, Baenke F, Cook M, McManus C, Sanchez-Laorden B, Dhomen N, Marais R.

Nat Med. 2019 Feb;25(2):350. doi: 10.1038/s41591-018-0325-y.

PMID:
30560902
4.

Ultraviolet radiation-induced DNA damage is prognostic for outcome in melanoma.

Trucco LD, Mundra PA, Hogan K, Garcia-Martinez P, Viros A, Mandal AK, Macagno N, Gaudy-Marqueste C, Allan D, Baenke F, Cook M, McManus C, Sanchez-Laorden B, Dhomen N, Marais R.

Nat Med. 2019 Feb;25(2):221-224. doi: 10.1038/s41591-018-0265-6. Epub 2018 Dec 3. Erratum in: Nat Med. 2018 Dec 18;:.

PMID:
30510256
5.

Metabotypes of breast cancer cell lines revealed by non-targeted metabolomics.

Dubuis S, Baenke F, Scherbichler N, Alexander LT, Schulze A, Zamboni N.

Metab Eng. 2017 Sep;43(Pt B):173-186. doi: 10.1016/j.ymben.2016.12.009. Epub 2016 Dec 27.

PMID:
28038952
6.

Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.

Girotti MR, Gremel G, Lee R, Galvani E, Rothwell D, Viros A, Mandal AK, Lim KH, Saturno G, Furney SJ, Baenke F, Pedersen M, Rogan J, Swan J, Smith M, Fusi A, Oudit D, Dhomen N, Brady G, Lorigan P, Dive C, Marais R.

Cancer Discov. 2016 Mar;6(3):286-99. doi: 10.1158/2159-8290.CD-15-1336. Epub 2015 Dec 29.

7.

Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells.

Baenke F, Chaneton B, Smith M, Van Den Broek N, Hogan K, Tang H, Viros A, Martin M, Galbraith L, Girotti MR, Dhomen N, Gottlieb E, Marais R.

Mol Oncol. 2016 Jan;10(1):73-84. doi: 10.1016/j.molonc.2015.08.003. Epub 2015 Aug 20.

8.

Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.

Baenke F, Dubuis S, Brault C, Weigelt B, Dankworth B, Griffiths B, Jiang M, Mackay A, Saunders B, Spencer-Dene B, Ros S, Stamp G, Reis-Filho JS, Howell M, Zamboni N, Schulze A.

J Pathol. 2015 Oct;237(2):152-65. doi: 10.1002/path.4562. Epub 2015 Jun 4.

PMID:
25965974
9.

A computational study of the Warburg effect identifies metabolic targets inhibiting cancer migration.

Yizhak K, Le Dévédec SE, Rogkoti VM, Baenke F, de Boer VC, Frezza C, Schulze A, van de Water B, Ruppin E.

Mol Syst Biol. 2014 Aug 1;10:744. doi: 10.15252/msb.20134993. Erratum in: Mol Syst Biol. 2014 Nov;10(11):765.

10.

Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development.

Baenke F, Peck B, Miess H, Schulze A.

Dis Model Mech. 2013 Nov;6(6):1353-63. doi: 10.1242/dmm.011338. Review.

11.

Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.

Ros S, Santos CR, Moco S, Baenke F, Kelly G, Howell M, Zamboni N, Schulze A.

Cancer Discov. 2012 Apr;2(4):328-43. doi: 10.1158/2159-8290.CD-11-0234. Epub 2012 Mar 22.

12.

Feedback control of p53 translation by REDD1 and mTORC1 limits the p53-dependent DNA damage response.

Vadysirisack DD, Baenke F, Ory B, Lei K, Ellisen LW.

Mol Cell Biol. 2011 Nov;31(21):4356-65. doi: 10.1128/MCB.05541-11. Epub 2011 Sep 6.

Supplemental Content

Loading ...
Support Center